Targacept: Life after nicotine

With its documented effects on the central nervous system, nicotine would be an attractive agent to investigate in various neurological conditions were it not for its side effects. Targacept, a spinout from R.J. Reynolds Tobacco Co., is using the tobacco giant's understanding of nicotine's effects to create non-nicotine compounds with improved selectivity that it says can eliminate those problems.

Targacept was spun out of RJR in 2000 armed with years of data on the chemistry

Read the full 746 word article

How to gain access

Continue reading with a
two-week free trial.